Evidence map›Paper›PMID 35935612›Full record

ArticleHemaSphere2022

Successful Retreatment With Venetoclax in a Patient With Chronic Lymphocytic Leukemia.

Ross A Jackson, Victoria M Smith, Sandrine Jayne, Cosima Drewes, Susanne Bens, Reiner Siebert, Martin J S Dyer, Harriet S Walter

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
  3. Landscape ofInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ross A JacksonThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom.
Victoria M SmithThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom.
Sandrine JayneThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom.
Cosima DrewesInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Germany.
Susanne BensInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Germany.
Reiner SiebertInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Germany.
Martin J S DyerThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom.
Harriet S WalterThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom.
University of Leicester · GBUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35935612
PMCPMC9351936
OpenAlexW4285491278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.